Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Trading Update

10 Jan 2006 07:00

Embargoed Release: 07:00hrs Tuesday 10th January 2006 SOPHEON PLC ("Sopheon") TRADING UPDATE Sopheon plc, the international provider of solutions that improve the returnfrom innovation and product development, announces that revenues for the secondhalf of 2005 are expected to be 40% higher than the ‚£1.9m reported for thefirst six months of the year. We closed 18 license transactions includingextension orders in the period, taking the total number of licensed customersto 70. Revenue growth in the US was particularly strong with turnover 60%higher than in the first half of the year. The revenue increase is expected toreduce the group's EBITDA losses for the second half of 2005 to under a thirdof the ‚£0.8m reported for the first six months. This expectation would havebeen for a breakeven second half, but for additional subcontractor costsincurred to deliver on services business which continued to run ahead ofhistoric trends.The above performance does not fully reflect the strength of our underlyingcommercial progress. In addition to the business closed last year, we have inhand conditional contracts and commitments that represent overall salespotential of the order of ‚£2m, of which approximately half could come throughin the shorter term. Originally targeted for completion in 2005, this business,together with other opportunities under negotiation, provides a strong positionto start the new year. In addition, our annual maintenance base coming into2006 has grown to over ‚£1.3m.Sopheon's strategic partnership with Microsoft is producing tangible businessimpact, with three Accolade license sales aided by support from Microsoft'ssales team. Seven new active business opportunities are a direct result ofjoint marketing at Microsoft events and such marketing activity will continuein 2006. Later this month, for example, Sopheon will be among a select group ofpartners that will be featured at the Microsoft Office Project 2006 Conferencefor end-users and partners in Seattle. During the period we also received freshmarket affirmation from IDC, a global IT research and advisory firm, whichcredited Sopheon with first-mover status for our actions to capitalize on theconvergence of the product life cycle management and portfolio managementmarkets.On the corporate front, Sopheon recently completed the full conversion of itsconvertible loan note, and renewed the group's ¢â€š¬10m equity line facility withGEM Global Yield Fund through December 2007.Financial expectations noted above are subject to the completion of theyear-end financial close process. Consistent with prior years, Sopheon plans toissue its 2005 preliminary results in early April. This will be brought forwarddepending on the speed with which the conversion to International FinancialReporting Standards is completed.Sopheon's Chairman, Barry Mence said:"While achieving 40% growth compared to the first half of the year is aconsiderable improvement, we are disappointed that continued sensitivity to thetiming of individual deals prevented us from exceeding even this performance,and that we were not able to achieve market expectations for earnings.Nevertheless, the extent of commercial activity in which we are engagedunderpins our continued confidence in the direction of our business. We look tofurther cement our leading position in our target markets as we move towardsthe important milestone of 100 licensed customers."For further information contact:Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245 1100 Andrew Tan + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010About SopheonSopheon (LSE:SPE) is an international provider of software and services thathelp organizations improve the business impact of product development. TheSopheon Accolade‚® product development system automates gate- or phase-basedproduct development (PD) processes and provides strategic decision support thatallows companies to improve innovation, cut product development spending wasteand shorten time to market. Sopheon is listed on the AIM market of the LondonStock Exchange and on the Euronext in the Netherlands. For more information,please visit www.sopheon.com.ENDSOPHEON PLC
Date   Source Headline
6th Dec 20137:00 amRNSDirector/PDMR Shareholding
5th Dec 20137:00 amRNSCorporate Update
19th Nov 20137:00 amRNSSopheon Delivers Accolade® Release 9.0
7th Nov 20137:00 amRNSInterim Management Statement
11th Sep 20133:00 pmRNSHolding(s) in Company
4th Sep 20133:00 pmRNSHolding(s) in Company
22nd Aug 20137:00 amRNSInterim Results
15th Aug 20133:00 pmRNSHolding(s) in Company
29th Jul 20133:00 pmRNSHolding(s) in Company
26th Jul 20137:00 amRNSTrading Update
15th Jul 20134:15 pmRNSHolding(s) in Company
28th Jun 20133:00 pmRNSTotal Voting Rights
27th Jun 20133:00 pmRNSHolding(s) in Company
19th Jun 20133:42 pmRNSHolding(s) in Company
19th Jun 20137:00 amRNSNew capabilities with Accolade(R) 8.3
14th Jun 20132:00 pmRNSContract Win
12th Jun 201312:00 pmRNSResult of AGM & GM
12th Jun 20137:00 amRNSAGM Statement
4th Jun 20137:00 amRNSIssue of Shares
2nd May 20137:00 amRNSInterim Management Statement
21st Mar 20137:00 amRNSPreliminary Results
30th Jan 20137:00 amRNSTrading Update
23rd Jan 20137:00 amRNSLaunch of Accolade 8.2
7th Dec 201211:36 amPRNHolding(s) in Company
8th Nov 20127:00 amPRNInterim Management Statement
1st Oct 20127:00 amRNSHolding(s) in Company
1st Oct 20127:00 amRNSDirectors' Options
24th Sep 20127:00 amRNSMarket Transfer to NYSE Alternext Concluded
23rd Aug 20127:00 amRNSAmendment to Terms of Convertible Loan Stock
23rd Aug 20127:00 amRNSInterim Results
23rd Jul 20127:00 amRNSTrading Update
13th Jun 20123:14 pmRNSResult of AGM
13th Jun 20127:00 amRNSAGM Statement
15th May 20127:00 amRNSAmendment to terms of Convertible Loan Stock
3rd May 20127:00 amRNSInterim Management Statement
25th Apr 20127:00 amRNSLaunch of Accolade 8.0
22nd Mar 20127:00 amRNSPreliminary Results
16th Feb 20127:00 amRNSTop 10 Solution Provider to CGM
31st Jan 20127:00 amRNSTrading Update
23rd Dec 201112:32 pmRNSExtension of GEM Equity Line
23rd Dec 201112:29 pmRNSTrading Update
5th Dec 201112:40 pmRNSHolding(s) in Company
3rd Nov 20117:00 amRNSInterim Management Statement
25th Aug 20117:00 amRNSInterim Results
25th Jul 20117:00 amRNSTrading Statement
23rd Jun 20112:15 pmRNSDirector/PDMR Shareholding
15th Jun 20117:00 amRNSAGM Statement
5th May 20117:00 amRNSInterim Management Statement
24th Mar 20117:00 amRNSPreliminary Results
10th Feb 20117:00 amPRNAppointment of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.